Follow-The-Filings

Holders · period archive

ARQT · Arcutis Biotherapeutics Inc.

Q3 2025 13F holders among managers we track latest ownership dossier

Ticker
ARQT
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares